NYSE:GEN Genesis Healthcare (GEN) Stock Price, News & Analysis Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$25.38▼$26.2750-Day Range$0.18▼$0.6052-Week Range$0.40▼$1.37Volume4.69 million shsAverage Volume4.10 million shsMarket Capitalization$16.67 billionP/E Ratio28.99Dividend Yield1.92%Price Target$26.20 Stock AnalysisStock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsStock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrends Get Genesis Healthcare alerts: Email Address Genesis Healthcare MarketRank™ Stock AnalysisAnalyst RatingHold2.40 Rating ScoreUpside/Downside0.4% Upside$26.20 Price TargetShort InterestN/ADividend StrengthModerateBased on Four FactorsSustainabilityN/ANews SentimentN/AInsider TradingSelling Shares$18.33 M Sold Last QuarterProj. Earnings Growth5.52%From $1.63 to $1.72 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.80 out of 5 starsBusiness Services Sector266th out of 317 stocksPrepackaged Software Industry181st out of 202 stocks 1.2 Analyst's Opinion Consensus RatingGenesis Healthcare has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on 2 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageGenesis Healthcare has only been the subject of 2 research reports in the past 90 days.Read more about Genesis Healthcare's stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for GEN. Previous Next 2.5 Dividend Strength Dividend YieldGenesis Healthcare pays a meaningful dividend of 3.05%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenesis Healthcare does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genesis Healthcare is 55.56%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Genesis Healthcare will have a dividend payout ratio of 29.07% next year. This indicates that Genesis Healthcare will be able to sustain or increase its dividend.Read more about Genesis Healthcare's dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GEN. Previous Next 1.1 News and Social Media Coverage Search Interest9 people have searched for GEN on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat Follows2 people have added Genesis Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Genesis Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $18,330,000.00 in company stock.Percentage Held by InsidersOnly 3.30% of the stock of Genesis Healthcare is held by insiders.Percentage Held by Institutions82.08% of the stock of Genesis Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genesis Healthcare's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Genesis Healthcare are expected to grow by 5.52% in the coming year, from $1.63 to $1.72 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Genesis Healthcare is 28.99, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 143.05.Price to Earnings Ratio vs. SectorThe P/E ratio of Genesis Healthcare is 28.99, which means that it is trading at a more expensive P/E ratio than the Business Services sector average P/E ratio of about 22.24. Previous Next See Top Rated MarketRank™ Stocks Here Ad The Oxford ClubDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...Click here now to claim your FREE copy of Marc's AI playbook. About Genesis Healthcare Stock (NYSE:GEN)Genesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.Read More Ad The Oxford ClubDon't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...Click here now to claim your FREE copy of Marc's AI playbook. GEN Stock News HeadlinesJuly 10, 2024 | prnewswire.comGen Launches Scam Artists to Highlight Emotional Toll of Cybercrime Through Creative ArtworkJuly 9, 2024 | prnewswire.comGen to Announce Fiscal 2025 First Quarter Results on August 1, 2024July 27, 2024 | The Oxford Club (Ad)Don't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...July 4, 2024 | investorplace.com7 Cybersecurity Stocks Set to Double on $1 Trillion Industry GrowthJune 4, 2024 | investorplace.com7 Meme Stocks That Actually Make Sense to OwnJune 3, 2024 | investorplace.com3 Underappreciated Cybersecurity Stocks to Buy NowMay 28, 2024 | prnewswire.comGen Releases its Fiscal 2024 Social Impact ReportMay 27, 2024 | msn.comJoint Genesis Reviews (BioDynamix) Is The Joint Support Formula Effective? Real Benefits, Results, Side-Effects & User Views!July 27, 2024 | The Oxford Club (Ad)Don't Pay a Dime for Marc Lichtenfeld's Top AI PicksUsually, you'd have to plunk down a hefty sum to get your hands on Marc Lichtenfeld's latest income research... But today, the author of Get Rich with Dividends is feeling extra generous...May 26, 2024 | msn.comGenesis Dealer’s Catastrophic Oil Change, Botched Fix Pushes Infuriated Owner To LexusMay 22, 2024 | msn.comNew York Attorney General Secures $2 Billion Settlement with Genesis to Compensate InvestorsMay 21, 2024 | finance.yahoo.comGenesis + HOCL to Showcase Revolutionary Clean Air Technology on 'Great Day Washington,' WUSA, Channel 9May 20, 2024 | forbes.comStarkey Executives Talk Hearing Aid Innovation, Developing Genesis AI, More In InterviewMay 17, 2024 | finance.yahoo.comGen Pledges To Help Close the Gender Gap in Europe’s Cybersecurity IndustryMay 16, 2024 | finance.yahoo.comInsider Sale: CFO Natalie Derse Sells 169,535 Shares of Gen Digital Inc (GEN)May 14, 2024 | msn.comGenesis thanks program for boosting reading levelsMay 14, 2024 | prnewswire.comDeepfakes, AI-Manipulated Audio, and Hijacked Social Media Surge in 2024May 13, 2024 | finance.yahoo.comStream Companies selected as Genesis Certified Digital Advertising VendorSee More Headlines Receive GEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genesis Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/09/2024Ex-Dividend for 6/12 Dividend5/17/2024Dividend Payable6/12/2024Today7/26/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorBusiness Services Industry Prepackaged software Sub-IndustryN/A Current SymbolNYSE:GEN Previous SymbolNYSE:SKH CUSIPN/A CIK1351051 Webwww.genesishcc.com Phone610-444-6350Fax302-636-5454Employees2,700Year FoundedN/APrice Target and Rating Average Stock Price Target$26.20 High Stock Price Target$29.00 Low Stock Price Target$25.00 Potential Upside/Downside+0.4%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.90 Trailing P/E Ratio28.99 Forward P/E Ratio16.01 P/E GrowthN/ANet Income$836 million Net Margins17.83% Pretax Margin23.69% Return on Equity155.48% Return on Assets9.12% Debt Debt-to-Equity Ratio7.50 Current Ratio0.48 Quick Ratio0.48 Sales & Book Value Annual Sales$2.80 billion Price / Sales5.96 Cash Flow$3.10 per share Price / Cash Flow8.42 Book Value($0.16) per share Price / Book-163.06Miscellaneous Outstanding Shares639,130,000Free Float618,038,000Market Cap$16.67 billion OptionableOptionable Beta0.84 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Robert H. Fish (Age 70)CEO & Director Comp: $411.5kMr. Thomas DiVittorio (Age 53)Exec. VP & CFO Comp: $565kMr. Paul David Bach (Age 62)COO & Exec. VP Comp: $630kMr. Stephen Scott Young (Age 49)Chief Accounting Officer & Treasurer Mr. Richard L. Castor (Age 66)Chief Information Officer & Sr. VP Mr. James W. Tabak (Age 62)Sr. VP of Admin. & Gov. Affairs Ms. Lori MayerVP of Investor Relations, Brand Management & Marketing CommunicationsMr. Michael Scott Sherman (Age 52)Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer Mr. Larry BaiderSr. VP of People Strategy & OperationsDr. JoAnne Susan Reifsnyder R.N. (Age 62)Ph.D., Ph.D., ACHPN, MSN, MBA, RN, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer More ExecutivesKey CompetitorsCrowdStrikeNASDAQ:CRWDPalantir TechnologiesNYSE:PLTRNetEaseNASDAQ:NTESAutodeskNASDAQ:ADSKAtlassianNASDAQ:TEAMView All CompetitorsInsiders & InstitutionsBank of New York Mellon CorpBought 131,337 shares on 7/26/2024Ownership: 0.842%Iridian Asset Management LLC CTSold 101,079 shares on 7/26/2024Ownership: 0.074%Allspring Global Investments Holdings LLCSold 22,697 shares on 7/26/2024Ownership: 0.043%State of Michigan Retirement SystemBought 3,400 shares on 7/26/2024Ownership: 0.029%Railway Pension Investments LtdBought 115,200 shares on 7/26/2024Ownership: 0.018%View All Insider TransactionsView All Institutional Transactions GEN Stock Analysis - Frequently Asked Questions How were Genesis Healthcare's earnings last quarter? Genesis Healthcare, Inc. (NYSE:GEN) announced its quarterly earnings data on Thursday, May, 9th. The company reported $0.48 earnings per share for the quarter, hitting analysts' consensus estimates of $0.48. Genesis Healthcare's quarterly revenue was up 2.1% on a year-over-year basis. Is Genesis Healthcare doing a stock buyback? Genesis Healthcare's board initiated a share repurchase program on Thursday, May 9th 2024, which permits the company to buy back $3,000,000,000 in shares, according to EventVestor. This means that the company could buy up to 23.1% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its stock is undervalued. Who are Genesis Healthcare's major shareholders? Top institutional shareholders of Genesis Healthcare include Bank of New York Mellon Corp (0.84%), Sumitomo Mitsui Trust Holdings Inc. (0.22%), Raymond James & Associates (0.19%) and Swedbank AB (0.09%). View institutional ownership trends. What other stocks do shareholders of Genesis Healthcare own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN) and Government Properties Income Trust (GOV). This page (NYSE:GEN) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GEN Stock Alerts